333 related articles for article (PubMed ID: 6461792)
41. Effects of coumarin (1,2-benzopyrone) on lymphocyte, natural killer cell, and monocyte functions in vitro.
Marshall ME; Conley D; Hollingsworth P; Brown S; Thompson JS
J Biol Response Mod; 1989 Feb; 8(1):70-85. PubMed ID: 2921611
[TBL] [Abstract][Full Text] [Related]
42. Elevated natural killer (NK) cytotoxicity of mononuclear leucocytes from splenectomized patients: increase in Leu-7+ and Leu-11+ leucocytes.
Ferrante A; Kiroff GK; Drew PA
Clin Exp Immunol; 1986 Apr; 64(1):173-80. PubMed ID: 3731525
[TBL] [Abstract][Full Text] [Related]
43. Human peripheral blood monocytes are susceptible to interferon-activated natural killer cells.
Einhorn S; Anderbring E
J Clin Lab Immunol; 1985 Apr; 16(4):197-9. PubMed ID: 4020850
[TBL] [Abstract][Full Text] [Related]
44. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
45. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
Smith BR; Rosenthal DS; Ault KA
Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of diminished natural killer cell activity in pregnant women and neonates.
Baley JE; Schacter BZ
J Immunol; 1985 May; 134(5):3042-8. PubMed ID: 3980989
[TBL] [Abstract][Full Text] [Related]
47. Natural killer cell function of human neonatal lymphocytes.
Uksila J; Lassila O; Hirvonen T
Clin Exp Immunol; 1982 Jun; 48(3):649-54. PubMed ID: 6180853
[TBL] [Abstract][Full Text] [Related]
48. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
Brown TE; Bankhurst AD; Strickland RG
J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
[TBL] [Abstract][Full Text] [Related]
49. Natural killer and tumor recognizing lymphocyte activity in tumor patients.
Klein E; Vánky F; Vose BM
Haematologia (Budap); 1978-1979; 12(1-4):107-12. PubMed ID: 395038
[TBL] [Abstract][Full Text] [Related]
50. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P
Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
[TBL] [Abstract][Full Text] [Related]
51. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
[TBL] [Abstract][Full Text] [Related]
52. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
Sharma B; Vaziri ND
Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
[TBL] [Abstract][Full Text] [Related]
53. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
54. Nonspecific human lymphocyte-mediated cytotoxicity induced by immobilized IgG aggregate: regulation by suppressor cells.
Fuson EW; Sugantharaj DG; Hubbard RA
J Clin Lab Immunol; 1982 Jan; 7(1):55-60. PubMed ID: 6461768
[TBL] [Abstract][Full Text] [Related]
55. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
[TBL] [Abstract][Full Text] [Related]
56. Mechanism of glucocorticoid action on murine natural killer cell activity.
Cox WI; Holbrook NJ; Friedman H
J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
[TBL] [Abstract][Full Text] [Related]
57. [Factors influencing depression of natural killer activity and its prevention in esophageal cancer patients].
Zeze K; Saito T; Kobayashi M
Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):22-33. PubMed ID: 2704363
[TBL] [Abstract][Full Text] [Related]
58. The "lazy" NK cells of Chediak-Higashi syndrome.
Targan SR; Oseas R
J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
[TBL] [Abstract][Full Text] [Related]
59. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
60. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
